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Abstract
VUR is a common condition and it is a predisposing factor for pyelonephritis, and reflux nephropathy, which
can cause end stage renal disease in children. Given the consequences and sequelae of UTI and VUR, and due
to lack of consensus regarding management of this common condition, the American Urological Association
(AUA) developed treatment guidelines for children with VUR in 1997 and 2012 to help physicians better
manage children with VUR. In this review, the summary of the 1997 and 2012 AUA guidelines are discussed
with a focus on the 2012 report. Recommendations about evaluation and management of children under and
above one year with VUR, with and without bladder/bowel dysfunction, screening of siblings of patients
with VUR, screening of the neonate/infant with prenatal hydronephrosis, and follow up of the children with
VUR are discussed in this review. The identification and management of VUR in these groups, provide the
potential opportunity to prevent renal damage and decrease the risk of UTI and pyelonephritis. According to
these guidelines, risk assessment of renal injury/scarring in the individual patient based upon clinical factors
is critical, and interventions should be appropriate to the risk profile. Informing families and healthcare
providers of the potential risk of pyelonephritis and renal scarring and allowing them to participate in
decision making is considered important.
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esicoureteral reflux (VUR) refers to retrograde flow of urine from
he bladder into the ureter and collecting system of the kidney [1].
UR is a common condition: between 3 and 5% of girls and 1–2%
f boys, experience urinary tract infection (UTI) before puberty [2].
UR is associated with higher rates (57%) of febrile UTI [1] and
pproximately 30–40% of children with UTI have reflux [3]. Reflux
s a predisposing factor for pyelonephritis, and reflux nephropa-
hy. The two important late complications of reflux nephropathy
re end stage renal disease and renin-mediated hypertension [4].
o identification and management of VUR provide the potential
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pportunity to prevent renal damage and decrease the risk of UTI
nd pyelonephritis. Currently, there are several treatment options
ncluding, observation, continuous antibiotic prophylaxis, and open,
ndoscopic or laparoscopic surgery.
ecause of the lack of consensus regarding management of this
ommon condition, the American Urological Association (AUA)
eveloped treatment guidelines for children with VUR in 1997 and
012 to help physicians better manage children with VUR.
n this review, the 1997 and 2012 AUA guidelines are discussed
ith a focus on the 2012 report.
nitial evaluation  of  VUR
eneral evaluations
he somatic growth curve is one of the best global parameters of
enal health in children [1]. Many children with VUR and UTI who
all below the normal growth curve, have normalized with successful
uppression of pyelonephritis with continuous antibiotic prevention
r surgical correction of reflux. So height and weight evaluation of
hese patients is necessary [5,6]. Furthermore, VUR is a primary
ause of significant hypertension in children so measurement of BP
hould be part of the primary evaluation of these patients [1].
aboratory  tests
rinalysis and urine culture, are important for confirmation of bac-
eriuria and UTI, and also allow the diagnosis of hematuria and
roteinuria. Serum creatinine measurement is important in evalua-
ion of renal function and GFR estimation [1].
ssessment of  upper  urinary  tract
he goal of upper tract imaging is the assessment of renal scarring
nd diagnosis of associated urinary tract anomalies. Most com-
only achieved with ultrasonography and DMSA renal scan. Renal
onography is useful for evaluation of hydronephrosis, renal dupli-
ation, and gross renal parenchymal abnormalities. The surface
reas of the kidney on renal sonography correlate with differential
enal function [7]. There is good correlation between sonographic
enal length and scintigraphic renal size [8]. However, following
n episode of pyelonephritis, renal scarring usually is apparent on
MSA, within 3 months, but may not be apparent on sonogra-
hy until 1–2 years later. So, the gold standard for assessing renal
arenchymal function is DMSA [1]. If the initial DMSA demon-
trated pyelonephritis, the follow-up scan at 6 month may show a
car [9]. The presence of reflux increases risk of permanent scarring
fter pyelonephritis. In addition greater number of UTIs, correlate
ith more scarring.
ssessment  of  lower  urinary  tract
he goal of lower urinary tract assessment is to assess bladder emp-
ying, anatomic abnormalities of bladder and urethra, and evaluation
f VUR. This information may be obtained with Voiding Cysto-
rethrography (VCUG) [1]. The RNC (radionuclide cystography)
s an alternative, low dose test that allows VUR diagnosis but with
imited anatomic detail. Cystoscopy and Urodynamic study may be
eneficial in children with voiding dysfunction [1].
p
I
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anagement  of  the  infants  under  1  year  with  VUR
ithout renal  scarring  at  diagnosis.  Infants with grades I–V reflux
hould be treated initially with continuous antibiotic prophylaxis.
f uncomplicated reflux continues, antibiotic prophylaxis should be
ontinued. For patients with persistent Grades I–II reflux, there is
o consensus regarding the role of continued antibiotic therapy,
eriodic cystography, or surgery. For patients with persistent uni-
ateral Grades III–IV reflux, surgical repair is the preferred option.
atients with persistent bilateral Grades III–IV reflux or Grade V
eflux should undergo surgical repair [10].
ith  renal  scarring  at  diagnosis.  Infants with Grades I–IV reflux
nd renal scarring should be treated initially with continuous antibi-
tic prophylaxis. In infants with Grade V reflux and scarring,
ontinuous antibiotic prophylaxis is the preferred option for initial
reatment, and surgical repair is a reasonable alternative. In patients
ith persistent Grades I–II reflux, there is no consensus regarding
he role of continued antibiotic prophylaxis, periodic cystography,
r surgery. In boys with persistent unilateral Grades III–IV reflux,
urgical repair is the preferred option. Boys with persistent bilat-
ral Grades III–IV reflux, girls with persistent Grades III–IV reflux,
nd boys and girls with persistent Grade V reflux should undergo
urgical repair [10].
he management of infants with VUR has become increasingly
ontroversial due to many systematic reviews, which support the
rotective role of circumcision and studies that question the time-
onored value of prescribing continuous antibiotic prophylaxis
CAP) and a shift to early treatment by endoscopic injection ther-
py [11]. In order to decrease the morbidity of UTI and the risk
f renal injury, treatment of VUR includes the options of observa-
ion, continues antibiotic prophylaxis and curative interventions as
ecommended.
ue to the greater morbidity from recurrent urinary tract infection,
ontinuous antibiotic prophylaxis is recommended for the child less
han one year of age with VUR with a history of a febrile urinary
ract infection. If there was no history of febrile urinary tract infec-
ion, continuous antibiotic prophylaxis is recommended for the child
ess than one year of age with VUR grades III–V who is identi-
ed through screening. This approach is optional for children with
rades I–II who are diagnosed through screening. Because of the
ncreased risk of urinary tract infection in boys who are not circum-
ised, circumcision of the male child with VUR may be considered.
here is not sufficient data to support this recommendation defi-
itely, but it is better to make parents aware of the potential benefit
11].
anagement  of  the  infants  over  1  year  with  VUR
ithout  renal  scarring  at  diagnosis.  Continuous antibiotic pro-
hylaxis is the best initial option for preschool children with Grades
–II reflux or unilateral Grades III–IV reflux and the preferred option
n children with bilateral Grades III–IV reflux. In patients with
nilateral Grade V reflux, continuous antibiotic prophylaxis is the
referred option for initial treatment, although surgical repair is a
easonable alternative. In patients with bilateral Grade V reflux,
urgical repair is the preferred option and continuous antibiotic
rophylaxis is a reasonable alternative [10].f uncomplicated reflux continues, antibiotic prophylaxis should
e continued. In children with persistent Grades I–II reflux, there
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2Summary of recent AUA guidelines for the management of vesicou
is no consensus regarding the role of continued antibiotic ther-
apy, periodic cystography or surgery. Surgery is the preferred
option for children with persistent Grades III–IV reflux. Patients
with persistent Grade V reflux should undergo surgical repair
[10].
With renal  scarring  at  diagnosis.  Preschool children with scarring
at diagnosis and either Grades I–II reflux or unilateral Grades III–IV
reflux should be treated initially with continuous antibiotic prophy-
laxis. Antibiotic therapy is the preferred option in children with
bilateral Grades III–IV reflux and scarring, and surgical repair is a
reasonable alternative. Surgery is the preferred option for patients
with unilateral Grade V reflux. Patients with bilateral Grade V dis-
ease and scarring should undergo surgical repair as initial treatment
[10].
In children with uncomplicated reflux, antibiotic prophylaxis should
be continued. In patients with persistent Grades I–II reflux after this
period of prophylaxis, there is no consensus regarding the role of
continued antibiotic prophylaxis, periodic cystography, or surgery.
Girls with persistent Grades III–IV reflux and boys with persis-
tent bilateral Grades III–IV reflux should undergo surgical repair.
Surgery is the preferred option for boys with persistent unilateral
Grades III–IV reflux and girls with bilateral Grades III–IV reflux.
For patients with persistent Grade V reflux, surgical repair is the
preferred option [10].
If symptoms of breakthrough urinary tract infection, such as fever,
dysuria, frequency, failure to thrive, or poor feeding develop, therapy
should be changed. Age, VUR grade, degree of renal scarring, and
evidence of abnormal voiding patterns, and parental preferences can
guide the physician to choose the best treatment [11].
For patients on continuous antibiotic prophylaxis with a febrile
breakthrough urinary tract infection open surgical ureteral reimplan-
tation or endoscopic injection of bulking agents is recommended.
For patients not receiving continuous antibiotic prophylaxis who
develop a febrile urinary tract infection, continuous antibiotic pro-
phylaxis should be initiated. In recent patients who develop a
non-febrile urinary tract infection, initiation of continuous antibiotic
prophylaxis is optional. For patients receiving continuous antibiotic
prophylaxis, who develop a single febrile breakthrough urinary tract
infection and no pre-existing or new renal cortical abnormalities, the
antibiotic agent, should be changed prior to definitive intervention
[11].
In summary, for children over one year with a history of UTI
and VUR, in the absence of dysfunctional elimination syndrome,
continuous antibiotic prophylaxis is a viable option. Observa-
tional management without continuous antibiotic prophylaxis, with
prompt antibiotic therapy for UTI may be considered [11].
Management  of  children  with  VUR  and  bladder/bowel
dysfunction
BBD (bladder/bowel dysfunction) refers to children with abnormal
storage and/or emptying. It includes lower urinary tract symptoms
such as urge incontinence, voiding postponement, and voiding dys-
function, and may also include abnormal bowel patterns, such as
constipation and encopresis. The most common cause is failure
of relaxation of the external sphincter and/or pelvic floor muscles
e
o
b
ual reflux in children 157
hich lead to high voiding pressures and incomplete evacuation.
he result of incomplete emptying of the bladder may predispose
he child to UTI [11].
ymptoms indicative of bladder/bowel dysfunction should be
xplored in the initial evaluation. In this situation, treatment of blad-
er/bowel dysfunction is indicated, preferably before any surgical
ntervention for VUR. There are insufficient data to recommend a
pecific treatment regimen for bladder/bowel dysfunction, but pos-
ible treatment options include: behavioral therapy, biofeedback,
nticholinergic medications, alpha blockers, and treatment of consti-
ation. Response of bladder/bowel dysfunction to treatment should
e monitored to determine whether treatment should be maintained
r modified. Based on the results of a meta-analysis, children with
BD are associated with decreased reflux resolution at 24 months,
nd a lower rate of correction after endoscopic surgery but not open
urgery. The incidence of baseline renal cortical abnormalities in
hildren with BBD was higher than in infants without BBD [11].
n summary, due to the increased risk of urinary tract infection, con-
inuous antibiotic prophylaxis is recommended for these children.
owever, they are associated with more UTIs on CAP both before
nd after surgical correction, so these children should undergo an
ssessment and appropriate treatment of voiding and bowel habits.
orrection of BBD should also be undertaken prior to surgical ther-
py, but there are some clinical conditions for which intervention
s considered imperative as an initial step including: uncontrolled
reakthrough UTIs or progressive renal damage. In that setting, open
urgical correction appears to have the greatest likelihood of cure
11].
creening of  siblings  and  of  patients  with  VUR
he incidence of VUR in the general population is about 1% because
t is a polygenic genetic disorder [4]. 100% concordance in identical
wins and 35–50% prevalence in fraternal twins is reported [12].
ystography of siblings and offspring of patients with VUR has
hown a high prevalence of VUR [13]. The goal of screening of
hese groups is detection of a population at risk and early treatment
n order to reduce the risk of adverse outcomes associated with VUR.
n the 1997 VUR guideline, a proposed future research goal was
o determine the impact of sibling and offspring screening with
arly medical or surgical treatment on the risk of these outcomes.
here were some questions to answer: Does screening and treat-
ent prevent UTI? Does screening and treatment prevent renal
amage? Is medical therapy effective in screened populations? In
rder to answer these questions, Skoog et al. performed a meta-
nalysis of 3040 children screened with a cystogram (2796 siblings,
nd 244 offspring) and the effects of treatment were assessed in
egards to resolution, urinary infections, and renal scarring [14].
he prevalence of VUR was 27.4% in siblings. The rate of renal
amage in asymptomatic sibling (without UTI) was 14.4% and for
creened siblings, some of whom were symptomatic was 22.8%,
uggesting that renal damage may be preventable in some cases.
n addition, there is no RCT nor prospective cohort studies that
ompare outcome in screened and non-screened siblings. So, the
012 AUA guideline, recommended screening in at risk cases. Any
vidence of renal scarring or renal size asymmetry on ultrasound
r a history of urinary tract infection in the sibling who has not
een tested, are indications for evaluation, so that a voiding cysto-
rethrogram or radionuclide cystography is recommended for these
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roups of patients. For other asymptomatic siblings, an observa-
ional approach without screening and prompt treatment of any acute
rinary tract infection and subsequent evaluation for VUR has been
ecommended AUA Guideline [11].
enal ultrasonography screening is helpful for the detection of sig-
ificant renal scarring, and the potential further risk of VUR [11].
creening the offspring of patients with VUR can be regarded sim-
larly to the screening of siblings [11].
creening of  the  neonate/infant  with  prenatal  hydronephrosis
renatal hydronephrosis (PNH) is defined as renal pelvic diam-
ter ≥5 mm during the second trimester and ≥8 mm during the
hird trimester of pregnancy [15]. The goal of postnatal evaluation
s to diagnose and manage vesicoureteral reflux before secondary
amage may occur from urinary tract infection.
n Skoog et al’s meta-analysis study involving 6579 infants with
NH; ultrasonography and VCUG were performed during the
eonatal period and first 3 months of life, respectively [14]. This
tudy demonstrated, VUR detected in an average of 16.2% of
atients, occurring more frequently in female than male (p  = 0.022).
he incidence of VUR grade was the same (33%) between SFU
Society of Fetal Urology) hydronephrosis Grade 1–2, Grade 3, and
rade 4–5. The incidence of reflux in the contralateral nondilated
idney was 4.1%. The VUR prevalence was independent of renal
elvic diameter (RPD) [11].
koog et al. noted that the incidence of renal cortical abnormality
efore UTI was 21.8% per patient and 32.3% per renal unit. Only 8
tudies reported on UTI during the post screening period. The inci-
ence of UTI averaged 4.2% in cases with reflux [14]. In summary,
he rate of reflux is approximately 16% (in compare to 1% of the gen-
ral population) and the incidence is independent of prenatal RPD,
nd may be detected in non-dilated renal units. Reflux is high grade
n two-thirds of patients. Renal cortical abnormalities occurred in
early 50% of those with grades IV–V. So, these considerations
otentially support postnatal cystography in all neonates with PNH.
owever, the lack of prospective studies demonstrating the benefit
f reflux detection in asymptomatic neonates and recent data from
rospective studies that question efficacy of antibiotic prophylaxis
o prevent UTI make screening cystography an option, rather than a
ecommendation [11]. Therefore, voiding cysto-urethrogram is rec-
mmended for children with high-grade (Society of Fetal Urology
rade 3 and 4) hydronephrosis, hydroureter or an abnormal bladder
n ultrasound (late term prenatal or postnatal), or those who develop
 urinary tract infection on observation [11].
or children with prenatally detected hydronephrosis (SFU grade 1
r 2) an observational approach without screening for VUR may be
ndicated. In this situation, a UTI mandates treatment followed by
CUG to screen for VUR [11].
ollow up  of  the  children  with  VURecommendation
he follow up interval is dependant upon likelihood of resolution,
s higher grades of reflux have lower resolution rates than lower
[M. Moradi, D.A. Diamond
rades, justifying a longer interval of follow up for these patients
s well as those in whom evidence supports lower rates of sponta-
eous resolution such as older patients and those with bladder/bowel
ysfunction [11].
n children with VUR yearly measurement of blood pressure, height
nd weight is recommended. Also, a yearly urinalysis and urine
ulture for evaluation of proteinuria and infection and ultrasonogra-
hy for evaluation of renal growth and scarring is recommended.
epending upon the prior reflux grade, a 12–24 month periodic
adionuclide cystography (RNC) is indicated, but this is optional
or grade 1 reflux. A single normal voiding cystogram is acceptable
o demonstrate resolution [11].
here are some indications for follow up with DMSA imaging for
hese patients including: abnormality in renal ultrasonography, con-
ern for renal scarring such as breakthrough pyelonephritis, elevated
erum creatinine and high grade reflux (grade III–V) [11].
onclusions
UR remains a clinical challenge and there is no definitive algo-
ithm to manage reflux. It is necessary to look at the total patient with
pecial attention on voiding function, age, grade of reflux, history
f UTI, presence of renal abnormalities and scarring, and parental
references. Hence, risk assessment of renal injury/scarring in the
ndividual patient based upon clinical factors is critical, and inter-
entions should be appropriate to the risk profile. Informing families
nd healthcare providers of the potential risk of pyelonephritis and
enal scarring and allowing them to participate in decision making
s considered important.
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